Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
Frontiers in Cell and Developmental Biology|January 28, 2026
The fall of the genome protectors triad: PBRM1, SETD2, and BAP1's impact on metabolism and immunity in clear cell renal cell carcinomaMathieu Johnson, Sandra TurcotteMolecular Oncology|November 26, 2024
Loss of SETD2 in wild-type VHL clear cell renal cell carcinoma sensitizes cells to STF-62247 and leads to DNA damage, cell cycle arrest, and cell death characteristic of pyroptosisMathieu Johnson, Sandra TurcotteCurrent Opinion in Cell Biology|January 9, 2010
Targeting cancer cells through autophagy for anticancer therapySandra Turcotte, Amato J GiacciaAdvances in Experimental Medicine and Biology|November 26, 2013
Autophagy and cell death to target cancer cells: exploiting synthetic lethality as cancer therapiesJulie Reyjal, Kevin Cormier, Sandra TurcotteFrontiers in Cell and Developmental Biology|January 3, 2022
A Compendium of Information on the LysosomeNadia Bouhamdani, Dominique Comeau, Sandra TurcotteJournal of Cell Science|April 17, 2003
HIF-1alpha mRNA and protein upregulation involves Rho GTPase expression during hypoxia in renal cell carcinomaSandra Turcotte, Richard R Desrosiers, Richard BéliveauAmerican Journal of Physiology. Renal Physiology|October 30, 2003
Hypoxia upregulates von Hippel-Lindau tumor-suppressor protein through RhoA-dependent activity in renal cell carcinomaSandra Turcotte, Richard R Desrosiers, Richard BeliveauAutophagy|September 5, 2008
Targeted therapy for the loss of von Hippel-Lindau in renal cell carcinoma: a novel molecule that induces autophagic cell deathSandra Turcotte, Patrick D Sutphin, Amato J GiacciaAmerican Journal of Physiology. Cell Physiology|February 14, 2019
STF-62247 accumulates in lysosomes and blocks late stages of autophagy to selectively target von Hippel-Lindau-inactivated cellsNadia Bouhamdani, Dominique Comeau, Kevin Cormier, et al.International Journal of Cancer|September 24, 2004
von Hippel-Lindau tumor suppressor protein stimulation by thrombin involves RhoA activationSandra Turcotte, Richard R Desrosiers, Geneviève Brand, et al.Pageof 3